National Institute of General Medical Sciences; Notice of Partially Closed Meeting
Published Date: 11/25/2025
Notice
Summary
The National Institute of General Medical Sciences is holding a virtual meeting on February 5, 2026, where part of the session will be open to the public and part will be closed to protect private info and trade secrets. Scientists and grant applicants are affected since grant reviews happen behind closed doors. Anyone can watch the open session online, and comments are welcome if sent a few days before the meeting.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Public Virtual Open Session
The National Institute of General Medical Sciences will hold a virtual open session on February 5, 2026, from 9:30 a.m. to 12:00 p.m. You can watch the videocast with closed captions at http://videocast.nih.gov and registration is not required; if you need sign language or other accommodations, request them at https://www.nigms.nih.gov/Pages/ContactUs.aspx at least 5 days before the event.
Closed Grant Review Session
On February 5, 2026, from 1:00 p.m. to 4:30 p.m., the meeting will be closed to review and evaluate grant applications under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information. Scientists and grant applicants are affected because their grant discussions and related confidential information will not be open to the public.
Public Comment Submission Rule
Any interested person may file written comments by emailing [email protected] at least 3 days before the February 5, 2026 meeting. Your statement should include your name, address, telephone number, and, if applicable, your business or professional affiliation.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-20998, Submission for OMB Review; Comment Request
The Department of Agriculture wants your thoughts on a form they use for NIFA grant applications. They’re checking if the form is useful, clear, and not too much work to fill out. If you have ideas or concerns, you’ve got until December 26, 2025, to speak up—no money changes, just making things better for everyone involved!
Next: 2025-21000, Publication of the Tier 2 Tax Rates
Starting in 2026, railroad workers, their employers, and employee reps will see new Tier 2 tax rates that help fund retirement benefits. Employees will pay 4.9% of their pay, while employers and reps will each pay 13.1%. These rates kick in for all 2026 earnings, so everyone involved should get ready for the change!